PLoS ONE (Jan 2021)

Management and outcomes of patients with chronic obstructive lung disease and lung cancer in a public healthcare system.

  • John R Goffin,
  • Sophie Corriveau,
  • Grace H Tang,
  • Gregory R Pond

DOI
https://doi.org/10.1371/journal.pone.0251886
Journal volume & issue
Vol. 16, no. 5
p. e0251886

Abstract

Read online

HypothesisThere is limited data on the care and outcomes of individuals with both chronic obstructive pulmonary disease (COPD) and lung cancer, particularly in advanced disease. We hypothesized such patients would receive less cancer treatment and have worse outcomes.MethodsWe analyzed administrative data from the province of Ontario including demographics, hospitalization records, physician billings, cancer diagnosis, and treatments. COPD was defined using the ICES-derived COPD cohort (1996-2014) with data from 2002 to 2014. Descriptive statistics and multivariable analyses were undertaken.ResultsOf 105 304 individuals with lung cancer, 43 375 (41%) had stage data and 36 738 (34.9%) had COPD. Those with COPD were likely to be younger, have a Charlson score ≤ 1, have lower income, to live rurally, and to have stage I/II lung cancer (29.8 vs 26.5%; all pConclusionsA co-diagnosis of COPD and lung cancer is associated with less curative treatment in early stage disease, less palliative treatment in late stage disease, and poorer outcomes.